b-cells

Documents about b-cells

• CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia#829817ClinicalTrials.gov
• CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma#876643ClinicalTrials.gov
• 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers#826141ClinicalTrials.gov
• CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas#349945ClinicalTrials.gov
• Chromatin unwinding state for in situ identification and lineage tracing of circulating tumor cells.#159834NCBI PubMed Central
• Neural stem cells shape intracellular calcium landscapes to control cell identity and function#293963bioRxiv / medRxiv
• PD-L2 regulates natural antibody and IL-10 secretion by B-1 cells#314853Europe PMC
• Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control#350582HAL (France)
• Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL#683080ClinicalTrials.gov
• Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells#1005515The University of Melbourne Library Digital Repository
• Multi-CAR-T Cells Targeting B Cell Lymphomas#883162ClinicalTrials.gov
• Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia#900293ClinicalTrials.gov
• A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma#435746ClinicalTrials.gov
• CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma#1032395ClinicalTrials.gov
• NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers#314321ClinicalTrials.gov
• Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)#835765ClinicalTrials.gov
• Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies#148752ClinicalTrials.gov
• Molecular and functional characterization of telomeric repeat-containing RNAs in Chinese hamster ovary cells#148822bioRxiv / medRxiv
• Emerging strategies for spinal cord injury repair: stem cells, extracellular vesicles, biomaterials, and neuromodulation.#415530NCBI PubMed Central
• Beyond B cells: T and Innate Immune Mechanisms of Autoimmunity in Common Variable Immunodeficiency.#615734NCBI PubMed Central
• Adipose Stem Cells for Traumatic Spinal Cord Injury#846651ClinicalTrials.gov
• PDGFRβ+ Stromal Cells Influence B Cell Dynamics and Chronic Stroke Outcomes via CXCL13 / Daniel Berchtold#1038111Deutsche Nationalbibliothek
• Pan-Atlantic University, <b>2026)2027 Admissions form has now been Released Officially</b>#300605Figshare
• Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma#825834ClinicalTrials.gov
• Costimulatory blockade depletes T peripheral helper, late-activated naive, and DN2 B cells in rheumatoid arthritis#10198bioRxiv / medRxiv
• CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy#290970ClinicalTrials.gov
• Convergent Met and voltage-gated Ca2+ channel signaling drives hypermigration of Toxoplasma-infected dendritic cells#316554Repositorio USS
• Role of mast cells in endomicrobial sepsis revisited: Mast cell-deficient mice show normal immunological protection#481623bioRxiv / medRxiv
• Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients#911555ClinicalTrials.gov
• Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease#992025ClinicalTrials.gov
• Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma#895420ClinicalTrials.gov
• Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL#1010466ClinicalTrials.gov
• Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients#838479ClinicalTrials.gov
• Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL#812671ClinicalTrials.gov
• A Phase II Study of the FIL on Elderly Frail Patients With DLBCL#856849ClinicalTrials.gov
• Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia#888560ClinicalTrials.gov
• Splenic follicular B cells promote adverse cardiac remodeling after myocardial infarction via MHC II-dependent antigen presentation.#15294bioRxiv / medRxiv
• AID and TET2 cooperate to demethylate Irf4 for plasma cell fate in germinal center B cells.#140707NCBI PubMed Central
• An "old" cytokine's new trick: IL-1β in B cells and the germinal center.#239786NCBI PubMed Central
• Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review).#380891NCBI PubMed Central
• Successful Use of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy with Lisocabtagene Maraleucel in a Renal Transplant Recipient with Refractory/Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)#219205ODU Digital Commons
• B‐Cell Differentiation of Human Hematopoietic Progenitors Is Efficiently Supported by Wharton Jelly‐Derived Mesenchymal Stem Cells#8366HAL (France)
• Data Sheet 1_Genotoxic stressors mimicking synovial microenvironment modulate B cell fate in RA-FLS co-culture.docx#361746Figshare
• Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination#846365ClinicalTrials.gov
• Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma#869555ClinicalTrials.gov
• Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL#917327ClinicalTrials.gov
• Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma#804017ClinicalTrials.gov
• Age-Associated Impairment of Paneth Cells Driven by microRNA-152 Promotes Intestinal Epithelial Vulnerability to Pathological Stress.#182549NCBI PubMed Central
• Age-associated B cells (ABCs) develop from a CNS-localized progenitor pool into a pro-inflammatory phenotype after stroke#221565bioRxiv / medRxiv
• Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma.#295254NCBI PubMed Central